Study suggests limited serum dilution can support rodent chemistry: full analysis

A new study on diluted rodent sera points to a potentially useful middle ground for preclinical clinical chemistry: limited dilution may preserve scarce sample volume without compromising most analytes. Based on the source summary, investigators evaluated 17 biochemical analytes in mice and rats on a Toshiba analyzer and concluded that 2.5-fold dilution was acceptable for most measures, but not for chloride, sodium, and total bilirubin in either species. That finding matters because rodent sample volume remains one of the most persistent operational constraints in laboratory animal medicine and preclinical safety studies. (frontiersin.org)

The background is straightforward. In mice and rats, especially in survival bleeds or small-study designs, labs often can't run a full chemistry panel from a single sample. That can push teams toward split testing, narrower analyte menus, or additional animals. Earlier work in mice found that diluted plasma could preserve interpretability for many analytes while freeing undiluted sample for electrolytes, with sodium, potassium, and chloride standing out as problematic. The authors of that 2016 study explicitly framed dilution as a way to reduce animal use and improve within-animal interpretation instead of relying on separate cohorts for different lab endpoints. (journals.sagepub.com)

At the same time, the broader literature has cautioned against assuming dilution is harmless. A 2018 Frontiers in Veterinary Science study evaluating diluted mouse and rat serum on a Siemens Dimension Xpand Plus found dilution-induced bias in a large majority of analytes, judged many results unacceptable under clinically conservative criteria, and warned that different dilution factors can confound comparisons across research groups. The authors also noted that predilution is generally discouraged in regulatory research, even if it may still have a place in exploratory settings when labs validate methods as fit for purpose. (frontiersin.org)

That makes the new report notable less as a universal practice change and more as a platform-specific validation signal. The source summary indicates that 2.5-fold dilution performed adequately for most of the 17 analytes tested on the Toshiba system, but not for chloride, sodium, and total bilirubin. Those exceptions are consistent with prior concerns that electrolytes and bilirubin-related measures are especially vulnerable to dilution effects or assay-range problems. The practical takeaway is that the acceptable dilution threshold appears to depend on the exact analyzer, analyte, and intended use of the data. (frontiersin.org)

Published expert commentary on this exact new study appears limited so far, but the strongest available industry perspective comes from comparative pathology literature. Jennifer Johns and colleagues wrote that the utility of data from prediluted samples “depends heavily on intended use,” and recommended that if predilution is used in exploratory research, all samples should be diluted to the same factor and interpreted within a validated framework. They also stressed that findings from one analyzer platform should not be generalized automatically to others. That caution is especially relevant here, since the new study used a Toshiba analyzer, while prior published rodent work used different systems and reached somewhat different acceptability thresholds. (frontiersin.org)

Why it matters: For veterinary professionals supporting preclinical programs, this study reinforces a careful but useful message: dilution can be a tool for sample stewardship, but only under controlled conditions. If a lab can validate a modest dilution factor for a defined analyte menu, it may reduce redraws, conserve terminal samples, and support 3Rs-aligned study design. But electrolytes and bilirubin still look like poor candidates for routine dilution-based workflows, and any temptation to mix dilution factors within a study could undermine comparability. In regulated environments, that limitation is especially important because even small analytical shifts can alter toxicologic interpretation. (frontiersin.org)

The study also fits a larger trend in laboratory animal medicine: pushing more information out of smaller specimens while maintaining analytical discipline. As microsampling and reduction strategies expand, chemistry validation work like this becomes more operationally important, not less. Labs, CROs, and comparative medicine teams increasingly need evidence-based rules for what can be diluted, how far, and on which platform. (frontiersin.org)

What to watch: Watch for a full paper or supplementary data that spell out the 17 analytes, dilution-performance thresholds, and species-by-species results, as well as any follow-up validation on other chemistry platforms before labs translate the finding into routine SOPs. (frontiersin.org)